With a $50 million initial investment from Flagship, Terrana will use RNA from benign plant viruses as a chassis to carry ...

While biopharmaceutical technologies have made substantial strides in treating diseases, drug research and development ...

Terrana is aiming to have commercially available products in the next few years, pending regulatory approval, that can be applied as sprayables or seed treatments. And the company says its RNA-based ...

A recent study involving researchers from the University of Basel reveals that slowing down the intracellular transport of ...

BUFFALO, NEW YORK / ACCESS Newswire / June 23, 2025 / ZeptoMetrix® is pleased to announce the launch of NATtrol™ Influenza A ...

Global Antisense and RNAi therapeutics Market is valued approximately at USD 3.69 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 18.72% over the forecast period ...

This application note explores the latest advanced acoustic fragmentation technology, which delivers consistent, high-quality ...

GeneCentric’s technology harnesses gene expression signatures from circulating RNA to deliver dynamic, real-time insights ...

By uncovering RNA’s previously unknown function to repair DNA damage, our findings show how RNA may directly contribute to the stability and evolution of the genome. It’s not merely a passive ...